PRESS RELEASE published on 05/16/2024 at 09:48, 1 year 9 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de UBISOFT ENTERTAINMENT par Morgan Stanley via ses filiales le 9 mai 2024 Capital Franchissement De Seuil Actions Morgan Stanley Ubisoft Entertainment
BRIEF published on 05/10/2024 at 09:23, 1 year 9 months ago Ubisoft Entertainment : mise à jour sur les droits de vote et les actions au 30 avril 2024 Euronext Paris Droits De Vote Capital Social AMF Ubisoft
BRIEF published on 05/10/2024 at 09:23, 1 year 9 months ago Ubisoft Entertainment: update on voting rights and shares as of April 30, 2024 Euronext Paris Share Capital Voting Rights AMF Ubisoft
PRESS RELEASE published on 05/10/2024 at 09:18, 1 year 9 months ago Informations sur les droits de vote et les actions au 30 avril 2024 Publication mensuelle du nombre total de droits de vote et d'actions composant le capital social d'Ubisoft Group pour avril 2024 conformément à l'article 223-16 du Règlement Général de l'AMF Euronext Paris Droits De Vote Capital Social AMF Ubisoft Group
Published on 02/21/2026 at 00:45, 1 day 15 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 15 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 17 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 18 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 12:19, 4 hours 4 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 6 hours 14 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 4 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 4 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 21 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 19:29, 1 day 20 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
